Simon N. Pimstone, CEO at Xenon Pharmaceuticals Inc. (XENE), sold 8,000 shares at $13.99 ($113K) on 2020-05-29, disclosed to the SEC on 2020-06-02.
Open-market sale of $113k XENE by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.99 | 5,000 | $70K | 61.8% |
| 2 | $14.43 | 3,000 | $43K | 38.2% |
| Total | $14.15 avg | 8,000 | $113K | 100% |
| Filing → |
| XENE | SELL | 2022-08-16 | $10.9M | — | Filing → |
| XENE | SELL | 2022-03-08 | $2.2M | — | Filing → |
| XENE | SELL | 2022-03-08 | $77K | — | Filing → |